These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 415919)

  • 41. Induction of resistance to ectromelia virus infection by corynebacterium parvum in murine peritoneal macrophages.
    Cohen DA; Bubel HC
    J Reticuloendothel Soc; 1983 Jan; 33(1):35-46. PubMed ID: 6300395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of macrophage in in vitro augmentation of rat, mouse, and human natural killer activities.
    Reynolds CW; Brunda MJ; Holden HT; Herberman RB
    J Natl Cancer Inst; 1981 May; 66(5):837-42. PubMed ID: 6164813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transduced monocyte/macrophages targeted to murine skin by UV light.
    Zhang AY; Wu C; Zhou L; Ismail SA; Tao J; McCormick LL; Cooper KD; Gilliam AC
    Exp Dermatol; 2006 Jan; 15(1):51-7. PubMed ID: 16364031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Corynebacterium parvum on the class and subclass of antibody produced in the response of different strains of mice to sheep erythrocytes.
    Warr GW; James K
    Immunology; 1975 Mar; 28(3):431-42. PubMed ID: 1092609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro anti-tumour properties of peritoneal exudate cells of conventional germ-free and stimulated mice.
    Fray A; Lorinet AM; Halpern B
    Dev Biol Stand; 1977 Apr 13-15; 38():241-4. PubMed ID: 608509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical experience in the use of C. parvum in the treatment of locally advanced carcinoma of the breast.
    Chare MJ; Webster DJ; Baum M
    Dev Biol Stand; 1977 Apr 13-15; 38():495-9. PubMed ID: 344104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colony stimulating and inhibiting activities in mouse serum after Corynebacterium parvum-endotoxin treatment.
    Shah RG; Green S; Moore MA
    J Reticuloendothel Soc; 1978 Jan; 23(1):29-41. PubMed ID: 304892
    [No Abstract]   [Full Text] [Related]  

  • 49. Antitumour effect of corynebacterium parvum. Possible mode of action.
    Baum M; Breese M
    Br J Cancer; 1976 Apr; 33(4):468-73. PubMed ID: 1268035
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of intravenous injection of two different strains of Corynebacterium parvum in the mouse.
    Sadler TE; Jones PD; Castro JE; Lampert IA
    Br J Exp Pathol; 1979 Dec; 60(6):627-31. PubMed ID: 540104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Corynebacterium parvum on hemopoietic stem-cell kinetics.
    Eliopoulos G; Andre S; Anagnou NP; Matsis C; Halpern B
    Int J Cancer; 1979 Jan; 23(1):114-8. PubMed ID: 759377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of corynebacterium parvum on bone marrow cell cultures (38557).
    Dimitrov NV; Andre S; Eliopoulos G; Halpern B
    Proc Soc Exp Biol Med; 1975 Feb; 148(2):440-2. PubMed ID: 1121493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of the Landschütz ascites carcinoma and ascitic fluid on macrophage activity in C. parvum-injected mice.
    McIntosh LC; Pugh-Humphreys RG; Thomson AW
    Br J Cancer; 1981 Apr; 43(4):496-504. PubMed ID: 7236491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanism of Corynebacterium Parvum anti-tumour activity. II. Protective effect in T-cell-deprived mice.
    Mazurek C; Chalvet H; Stiffel C; Biozzi G
    Int J Cancer; 1977 Oct; 20(4):532-4. PubMed ID: 334678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Haematological changes and iron metabolism in rats after administration of Corynebacterium parvum.
    Brozovic B; Sljivić VS; Warr GW
    Br J Exp Pathol; 1975 Apr; 56(2):183-92. PubMed ID: 1203175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The kinetics of mononuclear phagocytes in normal calves given Corynebacterium parvum.
    Al-Izzi SA; Maxie MG; Valli VE; Wilkie BN; Johnson JA
    Can J Comp Med; 1982 Apr; 46(2):138-45. PubMed ID: 7093810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunoproliferative alterations in lymphoid tissues and liver in mice stimulated with Corynebacterium parvum.
    Ellegaard J; Starklint H; Kragballe K; Dimitrov NV
    Acta Pathol Microbiol Scand C; 1978 Apr; 86(2):79-88. PubMed ID: 696333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of Corynebacterium parvum on murine cultured bone marrow cells].
    Eliopoulos G; André S; Halpern B; Dimitrov N
    C R Acad Hebd Seances Acad Sci D; 1976 Jan; 282(3):329-32. PubMed ID: 816561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modification of the effect of C. parvum on macrophage activity and tumour growth by X-irradiation.
    Woodruff MF; Ghaffar A; Whitehead VL
    Int J Cancer; 1976 May; 17(5):652-8. PubMed ID: 1270180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolonged effect of Corynebacterium parvum stimulation on granulopoiesis.
    Eliopoulos GD; Andre S; Anagnou NP; Fessas P
    Scand J Haematol; 1979 Nov; 23(5):353-9. PubMed ID: 542797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.